Amicus Taking Out 52-Week Lows (FOLD)

Posted in pre-market 
October 5th, 2009

Amicus Therapeutics (Nasdaq: FOLD) is effectively challenging its 52-week lows.  This one lost 24.7% of its value down to $6.40 on Friday evening after the close and traded some 59,900 shares in the after-hours session, and this morning at 8:44 AM EST we have seen a 27% drop to $6.20 on light trading.

The Phase II results in its Plicera(TM) type 1 Gaucher disease treatment stank up the office.   Amicus has a 52-week trading range of $6.26 to $15.26 and trades only about 35,000 shares per day.  Its market cap before the Friday and Monday drop was listed as $192.4 million.


Comments are closed